Infliximab for Crohn's disease in the Swiss IBD Cohort Study : clinical management and appropriateness

Juillerat, Pascal and Pittet, Valérie and Vader, John-Paul and Burnand, Bernard and Gonvers, Jean-Jacques and de Saussure, Philippe and Mottet, Christian and Seibold, Frank and Rogler, Gerhard and Sagmeister, Markus and Felley, Christian and Michetti, Pierre and Froehlich, Florian and Swiss IBD Cohort Study Group, . (2010) Infliximab for Crohn's disease in the Swiss IBD Cohort Study : clinical management and appropriateness. European journal of gastroenterology & hepatology, Vol. 22, H. 11. pp. 1352-1357.

Full text not available from this repository.

Official URL: http://edoc.unibas.ch/dok/A6003101

Downloads: Statistics Overview


Antitumor necrosis factor a agents have significantly improved the management of Crohn's disease (CD), but not all patients benefit from this therapy. We used data from the Swiss Inflammatory Bowel Disease Cohort Study and predefined appropriateness criteria to examine the appropriateness of use of infliximab (IFX) in CD patients.
Faculties and Departments:03 Faculty of Medicine > Bereich Medizinische Fächer (Klinik) > Gastroenterologie
03 Faculty of Medicine > Departement Klinische Forschung > Bereich Medizinische Fächer (Klinik) > Gastroenterologie
UniBasel Contributors:Froehlich, Florian
Item Type:Article, refereed
Article Subtype:Research Article
Bibsysno:Link to catalogue
Publisher:Lippincott Williams & Wilkins
Note:Publication type according to Uni Basel Research Database: Journal article
Related URLs:
Identification Number:
Last Modified:04 Jan 2013 08:37
Deposited On:04 Jan 2013 08:34

Repository Staff Only: item control page